WHR
65
-5
CAH
48
-6
SHW
62
-6
AMZN
61
-5
DOV
65
-4
SRE
63
2
ALLE
37
-4
VRSK
68
-12
GME
66
-5
APH
65
-3
KIM
72
2
HUM
41
-4
AON
54
2
KEY
43
-3
NWS
75
-4
ACN
47
-5
ETN
75
-3
MRK
17
-5
HRB
59
2
SJM
9
-5
WHR
65
-5
CAH
48
-6
SHW
62
-6
AMZN
61
-5
DOV
65
-4
SRE
63
2
ALLE
37
-4
VRSK
68
-12
GME
66
-5
APH
65
-3
KIM
72
2
HUM
41
-4
AON
54
2
KEY
43
-3
NWS
75
-4
ACN
47
-5
ETN
75
-3
MRK
17
-5
HRB
59
2
SJM
9
-5
Financhill
Back

CENTRAL & EASTERN EUROPE FUND, INC. Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
63

CEE
CENTRAL & EASTERN EUROPE FUND, INC.

Last Price:
11.80
Seasonality Move:
3.22%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
63
CENTRAL & EASTERN EUROPE FUND, INC. (CEE) is a Buy

Is CENTRAL & EASTERN EUROPE FUND, INC. a Buy, Sell or Hold?

  • The current CENTRAL & EASTERN EUROPE FUND, INC. [CEE] share price is $11.83. The Score for CEE is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • CEE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CEE Stock Price Chart

What is CENTRAL & EASTERN EUROPE FUND, INC.'s stock price today?

  • The CENTRAL & EASTERN EUROPE FUND, INC. share price today is $11.83
    The current trend is moderately bullish and CEE is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

CEE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.54 Buy
Relative Strength Index (14 RSI): 57.89 Buy
Chaikin Money Flow: -36161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.13 - 12.07) Buy
Bollinger Bands (100): (10.1 - 11.26) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

CEE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.4 Sell
20-day SMA: 11.3 Buy
50-day SMA: 10.76 Buy
200-day SMA: 10.28 Buy
8-day EMA: 12.15 Sell
20-day EMA: 11.57 Buy
50-day EMA: 11.01 Buy
200-day EMA: 10.34 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

CENTRAL & EASTERN EUROPE FUND, INC. Earnings Growth & CEE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

CENTRAL & EASTERN EUROPE FUND, INC. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):